The combination of anti-CTLA4 antibodies with fractionated irradiation (3 × 8 Gy or 5 × 6 Gy), but not single-dose irradiation (20 Gy), showed tumor growth delay outside the field of irradiation in preclinical models (300). Here, CTLA4 is linked to neoplasm.